⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Ivim Health GLP-1 Weight Loss Program: Individualized Dosing, Pricing, and What Consumers Should Know in 2026
globenewswire.com
LLY
NVO
Morgan & Morgan Secures $4.7 Million Verdict After Defeating Lowball $75,000 Offer in Orlando Trucking Crash
globenewswire.com
GOOG
META
LLY
Solve M.E. Funds GLP-1 and Immune Target Studies to Accelerate ME/CFS and Long Covid Breakthroughs
prnewswire.com
NVO
LLY
Bakar Labs Helps Companies Raise More Than $1 Billion in Its First Four Years of Operation
accessnewswire.com
AMGN
ABBV
JNJ
LLY
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
prnewswire.com
MRK
EXEL
LLY
ONCY
GILD
Jeito Capital Makes Significant Investment in the Second Closing of Alveus Therapeutics’ Oversubscribed Series A, Bringing Total Financing to $197 Million
globenewswire.com
ALV
SNY
LLY
Ivim Health GLP-1 Weight Loss: Cost Breakdown, Clinical Data, and What They Don't Tell You (2026)
accessnewswire.com
NVS
LLY
Flatiron Health Attends the 2026 American Society of Genitourinary Cancers Symposium to Answer Oncology's Most Critical Questions
businesswire.com
LLY
AMGN
AZN
MRK
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen
prnewswire.com
LLY
Novo Nordisk’s Wegovy® Pill Achieves Strong First-Month Uptake, Signaling Expanding Demand for Oral GLP-1s in Obesity
globenewswire.com
NVO
LLY